Castle Biosciences
CSTL
CSTL
163 hedge funds and large institutions have $1.29B invested in Castle Biosciences in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 144 → 163 (+19)
12.35% more ownership
Funds ownership: 68.35% → 80.7% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
163
Holding in Top 10
4
Calls
$8.19M
Puts
$3.16M
Top Buyers
| 1 | +$87.9M | |
| 2 | +$56.1M | |
| 3 | +$54.2M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$37.2M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$19.1M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$12.6M | |
| 3 | -$7.64M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.47M |
| 5 |
OFG
Oxford Financial Group
Carmel,
Indiana
|
-$4.41M |